These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2515610)

  • 1. Determination of plasminogen activator inhibitor (PAI) activity of human plasma after dilution in a PAI-depleted plasma.
    Contant G; Martinoli JL
    Thromb Res; 1989 Nov; 56(3):377-86. PubMed ID: 2515610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring plasminogen activator inhibitor activity in plasma by two enzymatic assays.
    Chiu WC; Gann DS; Darlington DN
    J Biochem Biophys Methods; 2000 Sep; 45(2):127-40. PubMed ID: 10989129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes.
    Levin RI; Harpel PC; Harpel JG; Recht PA
    Blood; 1989 Oct; 74(5):1635-43. PubMed ID: 2529003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay.
    Rånby M; Nguyen G; Scarabin PY; Samama M
    Thromb Haemost; 1989 Jun; 61(3):409-14. PubMed ID: 2508254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle.
    Stief TW; Lenz P; Becker U; Heimburger N
    Thromb Res; 1988 May; 50(4):559-73. PubMed ID: 3137681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C; Angles-Cano E
    Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
    Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced levels of tissue plasminogen activator and plasminogen activator inhibitor in plasma of patients with familial amyloidotic polyneuropathy.
    Olofsson BO; Nilsson TK
    Haemostasis; 1990; 20(1):31-6. PubMed ID: 2108913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay.
    Eriksson E; Rånby M; Gyzander E; Risberg B
    Thromb Res; 1988 Apr; 50(1):91-101. PubMed ID: 3135638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
    Lai HS; Chen Y; Chang KJ; Chen WJ
    J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM; Loskutoff DJ
    Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns.
    Corrigan JJ; Jeter MA
    Pediatrics; 1992 Jan; 89(1):43-6. PubMed ID: 1728019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
    Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
    Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
    Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
    Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the stability of tPA and PAI-1 during storage and handling of human plasma for in vitro studies: implications in the determination of tPA and PAI-1 activities.
    Hamon F; Masson-Lunven C; Boutière B; Boyer-Neumann C; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):393-9. PubMed ID: 2133216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of tissue plasminogen activator and plasminogen activator inhibitor in noninsulin-dependent diabetes mellitus.
    Matsuo T; Kadowaki S; Okada K; Matsuo O
    J Diabet Complications; 1990; 4(3):119-21. PubMed ID: 2147433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.